Intramuscular Neostigmine for urinary retntion after spinal anesthesia for knee arthroscopy
Not Applicable
Recruiting
- Conditions
- SurgeryAnaesthesia
- Registration Number
- PACTR202304565008785
- Lead Sponsor
- Mansoura university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients undergoing arthroscopic interventions under spinal anesthesia will be recruited for the study. Included patents will be of
both gender,
age from 18-44years,
ASA Physical Status Classification I-II.
Exclusion Criteria
Patients with diabetes millets,
on beta blockers,
prostatic hyperplasia,
previous pelvic surgery,
previous urologic surgery,
history of catheterization,
urogenital anomalies (incontinence, reflux),
renal impairment,
neurological disease
known allergy to neostigmine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie neostigmine's effect on postoperative urinary retention after spinal anesthesia?
How does intramuscular neostigmine compare to standard-of-care treatments for postoperative urinary retention in knee arthroscopy patients?
Are there specific biomarkers that predict response to neostigmine in postoperative urinary retention following spinal anesthesia?
What are the known adverse events associated with intramuscular neostigmine use in postoperative settings and how are they managed?
What alternative cholinergic agents or combination therapies are being explored for postoperative urinary retention management after spinal anesthesia?